Data / Form D filings / COAXIA INC
COAXIA INC: Form D filings
COAXIA INC, a biotechnology company in Maple Grove, MN, filed 2 Form D notices with the SEC between 2009 and 2011. The latest, on March 3, 2011, reports $22.5 million sold of a $22.5 million offering to 24 investors.
Find out what COAXIA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10900 73RD AVENUE NORTH, SUITE 102, Maple Grove, MN, 55369
- Phone
- (763) 315-1809
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1081070
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2011 | Amendment | $22,500,000 | $22,500,000 | $0 | 24 | Jun 19, 2009 | sec.gov |
| Jul 1, 2009 | New notice | $23,249,999 | $17,500,000 | $5,749,999 | 24 | Jun 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Denise Barbut | Director | |
| Peter Kristine Shagory | Director | |
| Andrew M. Weiss | Executive Officer, Director | |
| Brent Ahrens | Director | |
| Richard S. Schallhorn | Executive Officer | |
| Joshua S. Resnick | Director | |
| B. Kristine Johnson | Director | |
| James Bullock | Director | |
| Antoine S. Papiernik | Director | |
| Sharon D. Kvistad | Executive Officer | |
| Shelby S. Hautman | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Feb 28, 2011 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what COAXIA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.